Author: Asianet Pakistan

Posted on

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KSPI

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Kaspi.kz class action, go to https://rosenlegal.com/submit-form/?case_id=29172 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Kaspi.kz continued doing business with Russian entities, and also providing services to Russian citizens, after Russia’s 2022 invasion of Ukraine, thereby exposing Kaspi.kz to the undisclosed risk of sanctions; (2) Kaspi.kz engaged in undisclosed related party transactions; (3) certain of Kaspi.kz’s executives have links to reputed criminals; and (4) as a result, defendants’ statements about Kaspi.kz’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Kaspi.kz class action, go to https://rosenlegal.com/submit-form/?case_id=29172 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com


GlobeNewswire Distribution ID 9337251

Posted on

Workplace Options lance un programme complet et compatissant de retour au travail pour les personnes ayant survécu à un cancer

Une nouvelle approche en matière de soutien holistique, favorisant l’autonomisation des employés et mettant tous les outils nécessaires à la disposition des responsables pour une réintégration réussie

RALEIGH, Caroline du Nord, 24 janv. 2025 (GLOBE NEWSWIRE) — Le retour au travail après un diagnostic de cancer est un parcours semé d’embûches qui mêle fatigue physique, obstacles émotionnels et difficultés en matière de réintégration dans le monde du travail. Pour remédier à cette lacune majeure, Workplace Options (WPO), leader mondial en matière de solutions holistiques de santé et d’engagement des employés, présente le programme « Return to Work: Cancer Care Compass Program » (en français, « Retour au travail : programme Cancer Care Compass »).Il s’agit du premier programme mondial et inclusif conçu pour offrir un soutien sans égal aux employés qui se remettent d’un cancer et aux responsables qui les orientent dans leur transition vers le retour au travail.

Les difficultés rencontrées lors du retour au travail après un cancer
Pour les employés qui se remettent d’un cancer, le retour au travail passe souvent par les étapes suivantes :

  • Fatigue physique et difficultés cognitives ayant un impact sur la productivité quotidienne.
  • Problèmes émotionnels tels que l’anxiété, la peur du jugement ou la stigmatisation sur le lieu de travail.
  • Incertitude face à la dynamique du monde du travail et aux attentes en matière de performances.

Les employeurs sont eux aussi confrontés à des difficultés lorsqu’il s’agit de savoir comment apporter un soutien adéquat tout en s’alignant sur les priorités de l’entreprise. Les responsables peuvent avoir du mal à élaborer des aménagements modulables ou à favoriser l’intégration dans l’équipe.

Propositions du programme Cancer Care Compass pour surmonter ces difficultés
Le programme « Return to Work: Cancer Care Compass » a été conçu pour surmonter ces obstacles spécifiques grâce à une approche holistique à plusieurs niveaux :

  • Soutien émotionnel et psychologique : jusqu’à 18 séances de conseil, combinées à des séances de pleine conscience, contribuent au renforcement de la résilience des employés et de la gestion de leur stress.
  • Réintégration professionnelle : 12 séances de coaching personnalisées avec un coordinateur de la réinsertion et de l’adaptation professionnelles (CORAT), un spécialiste qui aide les employés à se fixer des objectifs réalisables, à améliorer leurs compétences et à relever les défis du monde du travail.
  • Évaluations fonctionnelles et recherches sur l’équilibre entre vie professionnelle et vie privée : Les spécialistes CORAT évaluent les besoins holistiques des employés et les mettent en contact avec des ressources essentielles, notamment des consultations diététiques, la rééducation physique, des aides à la mobilité et des thérapies complémentaires telles que l’acupuncture ou la yogathérapie.
  • Collaboration étroite avec les responsables : les spécialistes CORAT facilitent la communication entre les employés et les responsables, en veillant à ce que les plans d’adaptation et de réintégration soient adaptés aux besoins des deux parties.

Donner aux responsables les moyens de diriger avec confiance et compassion
Le programme Cancer Care Compass considère que les responsables jouent un rôle central dans la promotion d’un environnement de travail compatissant et inclusif. Les propositions du programme sont les suivantes :

  • Des consultations illimitées avec les responsables : les spécialistes CORAT offrent des conseils d’experts sur l’adaptation de l’environnement de travail et des plans de réintégration modulables.
  • Une boîte à outils destinée aux responsables : un guide en trois chapitres proposant des stratégies concrètes pour chaque étape de la réintégration :
    • Se préparer : comprendre les traitements anticancéreux, les dispositions sur le plan juridique et la planification modulable.
    • Agir : mettre en place des aménagements, gérer la dynamique de l’équipe et effectuer des contrôles.
    • Soutenir : apporter un soutien émotionnel et concret aux employés et aux équipes, tout en encourageant les responsables à se préserver.

« Les responsables sont les architectes d’une culture d’entreprise inclusive et psychologiquement saine », explique le Dr Kennette Harris, Chef de service clinique chez Workplace Options. « Ce programme leur fournit des outils spécifiques pour créer des environnements où les employés se sentent valorisés, soutenus et en mesure de donner le meilleur d’eux-mêmes. »

Ce qui distingue Workplace Options
Contrairement aux programmes traditionnels qui se concentrent uniquement sur le rétablissement médical, le programme Cancer Care Compass de WPO met l’accent sur la réintégration professionnelle et le renforcement de la résilience. Ses caractéristiques uniques sont les suivantes :

  • Un point de coordination unique : les spécialistes CORAT servent de ressource centrale pour les employés et les responsables, ce qui permet de simplifier le processus de réintégration.
  • Une adaptabilité à l’échelle mondiale : la conception évolutive du programme garantit qu’il répond aux divers besoins culturels et réglementaires des entreprises du monde entier.
  • Une approche holistique : en prenant en compte toutes les dimensions physiques, émotionnelles et professionnelles, le programme garantit un retour durable au travail.

Intégration harmonieuse aux politiques existantes
Le programme Cancer Care Compass complète le programme d’aide aux employés et de bien-être existant de l’entreprise. En s’alignant sur les politiques du milieu professionnel, il permet d’améliorer les systèmes de soutien tout en apportant une réponse aux difficultés spécifiques rencontrées par les employés et en favorisant un environnement inclusif.

Un engagement en faveur du rétablissement après un cancer et de l’intégration dans le monde du travail
En tant que signataire de l’engagement « Working with Cancer Pledge », WPO s’engage à créer des environnements de travail où les personnes ayant survécu à un cancer se sentent valorisées et responsabilisées à chaque étape de leur rétablissement.

« Le rétablissement après un cancer n’est pas seulement une question de survie, c’est aussi une question d’épanouissement », a déclaré Alan King, Président et directeur général de Workplace Options. « Grâce au programme Cancer Care Compass de WPO, nous aidons les employés à retourner au travail en toute confiance et les entreprises à élaborer des cultures de préservation durables. »

À propos de Workplace Options :

Fondée en 1982, Workplace Options (WPO) est le plus grand fournisseur indépendant de solutions holistiques de bien-être. À l’appui de programmes personnalisés et d’un réseau mondial exhaustif de prestataires et de professionnels agréés, WPO aide les travailleurs à se sentir plus heureux et plus productifs sur le plan personnel et professionnel, et contribue positivement à leur état de santé. Cinquante pour cent des entreprises classées Fortune 500 font confiance à WPO pour délivrer des soins de qualité supérieure par voie numérique ou en personne, à plus de 88 millions d’employés de quelque 127 000 entreprises implantées dans plus de 200 pays et régions.

Interlocutrice : Jennifer Dart, Responsable de la communication
[email protected]

Une vidéo accompagnant ce communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/87c8c114-e2ed-498f-8c98-a835046b9d6b


GlobeNewswire Distribution ID 9337333

Posted on

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ASP Isotopes Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ASPI

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline.

SO WHAT: If you purchased ASP Isotopes securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the ASP Isotopes class action, go to https:rosenlegal.com/submit-form/?case_id=32062 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) ASP Isotopes overstated the potential effectiveness of its enrichment technology; (2) ASP Isotopes overstated the development potential of its high assay low-enriched uranium facility; (3) ASP Isotopes overstated ASP Isotopes’ nuclear fuels operating segment results; and (4) as a result of the foregoing, defendants’ positive statements about ASP Isotopes’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the ASP Isotopes class action, go to https://rosenlegal.com/submit-form/?case_id=32062 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9337254

Posted on

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aehr Test Systems Investors to Secure Counsel Before Important Deadline in Securities Class Action – AEHR

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on Aehr’s revenue growth; (3) accordingly, Aehr’s business and/or financial prospects were overstated; and (4) as a result, Aehr’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9337245

Posted on

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aehr Test Systems Investors to Secure Counsel Before Important Deadline in Securities Class Action – AEHR

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on Aehr’s revenue growth; (3) accordingly, Aehr’s business and/or financial prospects were overstated; and (4) as a result, Aehr’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9337245

Posted on

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aehr Test Systems Investors to Secure Counsel Before Important Deadline in Securities Class Action – AEHR

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on Aehr’s revenue growth; (3) accordingly, Aehr’s business and/or financial prospects were overstated; and (4) as a result, Aehr’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9337245